TickerGuard
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Raymond James Financial Inc. (RJF)

Financial Services Asset Management
176.00 $
+0.6% vs. previous close
Closing price · As of: 31. Jul 2026
🔔 Watch stock

Stock Watch

Stock Watch will tell you what changes at Raymond James Financial Inc..

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Appears in These Scanners

This stock currently matches 9 of our scanner strategies — each hit links to the scanner.

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Trading Day

Previous Close
175.00$
Open
175.00$
Day High
176.90$
Day Low
174.60$
Volume
1,192,288shares

Key levels of the most recently completed trading day — not a live quote.

52-Week Range

52-Week Low 52-Week High
140.90 $ 177.20 $
03/30/2026 07/28/2026

Current price 176.00 $ — 97% of the range above the low.

Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.

Basics

Market Cap
34.4$B
Shares Outstanding
192Mio.
Float
89.3%
Beta
0.9

Performance

Perf. 1M
5.00%
Perf. 3M
5.90%
Perf. 6M
-9.40%
YTD Performance (%)
-1.30%
52-Week-High Distance
-15.3%
Perf. 1Y
6.73%
Perf. 3Y
66.85%
Perf. 5Y
119.03%
Perf. 10Y
456.71%
Perf. Since Inception
71,728.57%

Technical Indicators

MA 38 Days
162.40$
MA 50 Days
159.00$
MA 200 Days
158.30$
RSI (14)
67.9
Volatility 30 Days
25.8%
Volatility 250 Days
25.5%

Calculated from the price history · as of 08/03/2026

Valuation

P/E
16.6
Forward P/E
12.5
PEG
0.9
P/B
2.7
P/S
2.1
EV/EBITDA
0.0
Price/FCF
14.4

Profitability

Gross Margin
93.2%
EBIT Margin
19.3%
Net Margin
15.1%
Return on Equity
17.3%
Return on Assets
2.5%

Balance Sheet & Safety

Equity Ratio
13.7%
Debt/Equity
0.5
Altman Z″
1.11
Piotroski
6 out of 9

Growth

Sales Growth Last Quarter
13.10%
EPS Growth Last Quarter
15.30%
Sales Growth (Year)
7.94%
Forward Sales Growth
7.51%
Forward EPS Growth
12.70%

Dividend

Dividend Yield
1.23%
Dividend Per Share (TTM)
2.12$
Payout Ratio
17.9%
Years Without a Cut
1Years
Increase Streak
1Years

Quality & Screener

Stage
3
RS Rating
38
EPS Rating
62
Piotroski
6 out of 9
Fundamental Rating
B (56 out of 100)
Altman Z″
1.11

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built

Analysts & Price Target

Current Price 176.00 $
Price Target (average) 185.92 $

The price target sits 5.6% above the current price.

Consensus
Hold
Analyst Ratings
14
Distribution of Recommendations
Strong Buy 2
Buy 2
Hold 10
Sell 0
Strong Sell 0

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
09/30/2026 12.12 11.65 – 12.41 15,739 13.7% 14
09/30/2027 14.18 12.55 – 15.08 17,450 17.0% 14

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Next Reporting Date

28. Oct 2026 · after the close · Q3 2026
Expected Earnings per Share
3.33 $

Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 3,982.0 $M Q4 2025: Q1 · 3,791.0 $M Q1 2025: Q2 · 3,786.0 $M Q2 2025: Q3 · 4,130.0 $M Q3 2025: Q4 · 4,176.0 $M Q4 2026: Q1 · 4,262.0 $M Q1

Source: fundamental data

Compare with other stocks →

Quarterly Figures

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 2.87 23.10 3,982 14.40 15.10 830 789
2025: Q1 2.37 6.30 3,791 5.50 13.10 117 71
2025: Q2 2.12 -8.40 3,786 1.90 11.50 691 634
2025: Q3 2.92 3.10 4,130 4.50 14.60 796 752
2025: Q4 2.80 -2.50 4,176 4.90 13.50 -10 -56
2026: Q1 2.73 15.10 4,262 12.40 12.80 1,099 1,054
What Do These Terms Mean?
EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Annual Figures

Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2016 5,461 812 529 2.44 -518 4,917 31,487
2017 6,446 925 636 2.89 -125 5,693 34,883
2018 7,384 1,311 857 3.84 884 6,452 37,413
2019 7,929 1,375 1,034 4.79 577 6,643 38,830
2020 8,067 1,052 818 3.89 4,054 7,176 47,482
2021 9,780 1,791 1,403 6.64 6,625 8,303 61,891
2022 11,156 2,022 1,509 7.01 72 9,432 80,951
2023 11,468 7,213 1,739 8.02 -3,514 10,214 78,360
2024 14,741 2,643 2,068 9.74 2,155 11,673 82,992
2025 15,912 4,561 2,135 10.33 2,434 12,503 88,230

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

About the Company

Raymond James Financial, Inc. ist ein diversifiziertes Finanzdienstleistungsunternehmen, das Private-Client-Group-, Kapitalmarkt-, Asset-Management-, Bank- und andere Dienste für Privatpersonen, Konzerne und Kommunen in den USA, Kanada und Europa anbietet.

Employees19,500
HeadquartersSaint Petersburg, FL
Address880 Carillon Parkway, 33716 Saint Petersburg, United States
Phone727 567 1000
Websiteraymondjames.com
IPO Date30. Dec 1987
ISINUS7547301090
Stock Split3:2 on 09/22/2021

Management

Management
Name Title Birth Year
Paul Christopher Reilly CPA Executive Chair 1955
Paul Marone Shoukry CEO & Director 1983
Jonathan W. Oorlog Jr. Senior VP, CFO & Controller 1964
Scott Alan Curtis Chief Operating Officer 1963
Tashtego Spring Elwyn President of Private Client Group 1972
James E. Bunn President of Capital Markets & Advisory 1973
Katherine H. Larson Chief Accounting Officer 1981
Andy Zolper Chief information officer
Bella Loykhter Allaire Chief Administrative Officer 1953
Kristina Waugh Senior Vice President of Investor Relations and FP&A

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
28. Jul 2026 Elwyn Tashtego S President, PCG Sell 10,000 176.06 1,760,552
27. Jul 2026 Raney Steven M Executive Chair RJBank Sell 5,770 172.97 998,033

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Chart

Interactive price chart (TradingView).

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?